Dosing strategies for MLN8054, a selective Aurora A kinase inhibitor, based on pharmacokinetic modeling and simulations

  1. Lee, Y.
  2. Eton, O.
  3. Pappas, J.
  4. Chen, S.
  5. Paton, M.
  6. Dees, E. C.
  7. Jones, S.
  8. Cohen, R. B.
  9. Cervantes, A.
  10. Tabernero, J.
Revue:
EJC SUPPLEMENTS

ISSN: 1359-6349

Année de publication: 2008

Volumen: 6

Número: 12

Pages: 130-131

Congreso: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Type: Communication dans un congrès

DOI: 10.1016/S1359-6349(08)72349-8 GOOGLE SCHOLAR